Allergan Aquisition of Aczone

Allergan has a strong infrastructure to support dermatologic and aesthetic products.  Aczone, an aqueous topical gel containing 5% dapsone, will be a new product which will help treat patients with acne.  "The strength of topical dapsone gel appears to be its high efficacy against inflammatory acne lesions.  Both rapid onset of action and tolerability make this agent a potentially...

This article is important in that this acquisition is the first new product for Allergan's dermatology division in several years. This is also the first novel molecule in 5-7 years that has been released. The issues of having to get blood tests with this topical agent have been solved. The obvious paring of this antiinflammtory with Allergan's Tazorac retinoid product will drive sales of both products....